Literature DB >> 1973595

The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase.

O Nilssen1, O H Førde, T Brenn.   

Abstract

Gamma-glutamyltransferase was measured in 10,942 males aged 12-62 years and 10,840 females aged 12-59 years screened in a health survey program. The distribution was right-skewed, with medians of 17 and 12 units/liter for males and females, respectively. Fewer than 5.5% of the males and 1.5% of the females had values exceeding 50 units/liter, reflecting the modest use of alcohol in Norway. In sex-specific multiple regression analyses, gamma-glutamyl-transferase showed a strong positive association with body mass index, alcohol use, and total serum cholesterol and a somewhat weaker positive association with serum triglycerides, high density lipoprotein cholesterol, heart rate, blood pressure, use of analgesics, and time since last meal. Strong negative associations were found for coffee consumption, hour of the day at which the examination was performed and, in males, physical activity. In females, use of oral contraceptives and menopause were positively associated with gamma-glutamyltransferase, whereas pregnant females had lower values. In conclusion, the gamma-glutamyltransferase level in the Tromsø population was low, with marked and consistent sex differences which probably are physiologic. Within its normal range, gamma-glutamyltransferase has many other, even stronger determinants than alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973595     DOI: 10.1093/oxfordjournals.aje.a115661

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

1.  Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project.

Authors:  M L Bots; J T Salonen; P C Elwood; Y Nikitin; A Freire de Concalves; D Inzitari; J Sivenius; A Trichopoulou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study.

Authors:  Saverio Stranges; Maurizio Trevisan; Joan M Dorn; Jacek Dmochowski; Richard P Donahue
Journal:  Hypertension       Date:  2005-10-03       Impact factor: 10.190

3.  Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men.

Authors:  N Nakanishi; K Nakamura; K Nakajima; K Suzuki; K Tatara
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

Review 4.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

5.  Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.

Authors:  Qian Xiao; Rashmi Sinha; Barry I Graubard; Neal D Freedman
Journal:  Hepatology       Date:  2014-10-30       Impact factor: 17.425

6.  Gamma-glutamyltransferase and diabetes--a 4 year follow-up study.

Authors:  D-H Lee; M-H Ha; J-H Kim; D C Christiani; M D Gross; M Steffes; R Blomhoff; D R Jacobs
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

7.  Racial/Ethnic-Specific Reference Intervals for Common Laboratory Tests: A Comparison among Asians, Blacks, Hispanics, and White.

Authors:  Eunjung Lim; Jill Miyamura; John J Chen
Journal:  Hawaii J Med Public Health       Date:  2015-09

8.  Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group.

Authors:  F Pintus; P Mascia
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 9.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

10.  Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease.

Authors:  Mahmut Ilker Yilmaz; Faruk Turgut; Mehmet Kanbay; Mutlu Saglam; Alper Sonmez; Halil Yaman; Seref Demirbas; Hilmi Umut Unal; Mahmut Gok; Murat Karaman; Seyit Ahmet Ay; Erkan Demirkaya; Adrian Covic; Juan Jesus Carrero
Journal:  Int Urol Nephrol       Date:  2012-12-15       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.